SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbmu.ac.ir/
Short Daily Versus Conventional Hemodialysis for COVID-19 Patients
Not Applicable
Completed
- Conditions
- COVID-19
- Interventions
- Other: Short daily dialysis
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 47
- Registration Number
- NCT05212675
- Locations
- 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of
Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
Phase 3
Completed
- Conditions
- CardiomyopathiesSystolic DysfunctionChemotherapy EffectDiastolic Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2022-01-03
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05175066
- Locations
- 🇮🇷
Rasool Akram hospital, Tehran, Iran, Islamic Republic of
Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery
Phase 3
Completed
- Conditions
- Vomiting, PostoperativePerioperative ComplicationNauseaBariatric Surgery CandidateDrug Effect
- Interventions
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 130
- Registration Number
- NCT05087615
- Locations
- 🇮🇷
Loghman Hakim Hospital, Tehran, Iran, Islamic Republic of
Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema
Phase 2
- Conditions
- Diabetic Macular Edema
- Interventions
- Drug: Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 62
- Registration Number
- NCT05083689
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration
Phase 1
- Conditions
- Age Related Macular Degeneration
- Interventions
- Drug: PlaceboDrug: Oral intake of medication
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05005884
- Locations
- 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of
Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity
Not Applicable
Completed
- Conditions
- BlindnessVision Impairment
- Interventions
- Other: Assessment of distance and near visual acuity using the conventional methodsDevice: Assessment of distance and near visual acuity using "Vision Screening module" of "Easy Vision" applicationDevice: Assessment of distance and near visual acuity using "Test Yourself module" of "Easy Vision" applicationDevice: Assessment of distance and near visual acuity using "Peek Acuity" application
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT04936100
- Locations
- 🇮🇷
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of
Hemodialysis-Induced Blood Pressure Change In End-Stage Renal Disease
Completed
- Conditions
- Hemodialysis
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT04933006
- Locations
- 🇮🇷
SBMU, Tehran, Iran, Islamic Republic of
Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation
Not Applicable
Recruiting
- Conditions
- Kidney Transplant; Complications
- Interventions
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04918407
- Locations
- 🇮🇷
SBMU, Tehran, Iran, Islamic Republic of
🇮🇷Labbafinezhd Hospital, Tehran, Iran, Islamic Republic of
Comparison of Safety and Efficacy of de Novo Everolimus
Not Applicable
Completed
- Conditions
- Cytomegalovirus Infections
- Interventions
- Drug: Sandimmun (Neoral) dose plus cellcept
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2021-05-28
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 35
- Registration Number
- NCT04906304
- Locations
- 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of
Relationship Between CT- Value With Prognosis in COVID-19 Patients
Completed
- Conditions
- COVID-19
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT04902157
- Locations
- 🇮🇷
SBMU, Tehran, Iran, Islamic Republic of
🇮🇷Nooshin Dalili, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath